Lifeboat Foundation

CRISPR to take bio- and dirty-bombs to new levels.
Great; however, QC needs to be front and center on this; or, I see a bunch of funding spent on research that will be render useless by the time it goes to market due to the progress in QC.

I truly feel bad for the labs who are having to tests for bio- and dirty-bomb material. Really a dangerous job.

The Defense Advanced Research Projects Agency (DARPA) is looking for research proposals to develop a system that would enable the government and law enforcement to identify the actual individual behind a cyber attack.

Continue reading “DARPA looking to develop new technology to ID cybercriminals” »

By David Glance Director of UWA Centre for Software Practice, University of Western Australia

Pharmaceutical companies typically develop new drugs with thousands of staff and budgets that run into the billions of dollars. One estimate puts the cost of bringing a new drug to market at $2.6 billion with others suggesting that it could be double that cost at $5 billion.

Continue reading “Garage Biotech: New drugs using only a computer, the internet and free online data” »

Japanese scientists have reported the first successful skin-to-eye stem cell transplant in humans, where stem cells derived from a patient’s skin were transplanted into her eye to partially restore lost vision.

The patient, a 70-year-old woman diagnosed with age-related macular degeneration (AMD) – the leading cause of vision impairment in older people – received the experimental treatment back in 2014 as part of a pilot study. Now, closing in on two years after the transplant took place, the scientists are sharing the results.

The researchers took a small piece of skin from her arm (4 mm in diameter) and modified its cells, effectively reprogramming them into induced pluripotent stem cells (iPSC).

Continue reading “Japanese scientists have used skin cells to restore a patient’s vision for the first time” »

Something so simple and finally done to help so many.

Beautiful

Researchers at the University of California said the new system dramatically improves the ability of people with limited sight to read books, menus, newspapers and emails.

Continue reading “OrCam headset recognises faces, objects and reads words aloud” »

Nice

A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment.

The study in rats showed transfer of a gene known as KCC2 into the spinal canal restored chloride levels gone awry after nerve injury. Results from the research at The University of Texas MD Anderson Cancer Center, were published in the May 5 online issue of Cell Reports.

Continue reading “Gene therapy could be potential treatment for neuropathic pain in cancer patients” »

A gene therapy for an inherited immune disease completes a 27-year journey.

Organoids grown from genetically edited stem cells are giving scientists a new tool to screen drugs and test treatments.

Cell phones do not cause brain cancer.

Mobile phone use has not caused a rise in brain cancer in Australia, says a new study led by the University of Sydney.

Ido Bachelet, Shawn Douglas and George Church filed a patent in 2011 for DNA origami devices useful in the targeted delivery of biologically active entities to specific cell populations.

This is the patent for the DNA nanorobot for molecular precise delivery of treatments to cells. This has been covered several times by Nextbigfuture

Their DNA origami device comprises a scaffold strand and a plurality of staple strands, wherein:

Continue reading “Original Patent details on DNA Origami Molecular buckets which enables nanomedicine” »